دورية أكاديمية

Quantification of Acipimox in Plasma and Tissues by LC–MS/MS: Application to Pharmacokinetic Comparison between Normoxia and Hypoxia.

التفاصيل البيبلوغرافية
العنوان: Quantification of Acipimox in Plasma and Tissues by LC–MS/MS: Application to Pharmacokinetic Comparison between Normoxia and Hypoxia.
المؤلفون: Shen, Xin, Li, Gaofu, Wang, Libin, Yu, Huijin, Zhou, Lei, Deng, Huifang, Wang, Ningning, Lai, Chengcai, Zhou, Wei, Gao, Yue
المصدر: Molecules; Oct2022, Vol. 27 Issue 19, p6413, 16p
مصطلحات موضوعية: LIQUID chromatography-mass spectrometry, LIPID metabolism, HYPOXEMIA, PHARMACOKINETICS, FREE fatty acids, HYPOXIA-inducible factor 1, WESTERN immunoblotting
الشركة/الكيان: EUROPEAN Medicines Agency, UNITED States. Food & Drug Administration
مستخلص: This study aimed to evaluate the pharmacokinetics of acipimox in rats under simulated high altitude hypoxia conditions. A sensitive and reliable LC–MS/MS method has been established for the quantitation of acipimox in rat plasma and tissue homogenate and validated according to the guidelines of the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). Western blotting and enzyme linked immunosorbent assay (ELISA) were used to investigate the expression of lipid metabolism-related proteins and free fatty acid (FFA) levels, respectively. Cell viability was detected using a Cell Counting kit-8 assay (CCK-8). The method was then successfully applied in a pharmacokinetic comparison between normoxic and hypoxic rats. The results indicated that there were significant differences in the main pharmacokinetics parameters of acipimox between normoxic and hypoxic rats. HCAR2 expression in the hypoxia group was upregulated compared to that in the normoxia group and the levels of FFA decreased more in the hypoxia group. Under the hypoxia condition, the proliferation of HK2 cells was inhibited with increasing concentrations of acipimox. The results provide important and valuable information for the safety and efficacy of acipimox, which indicated that the dosage of acipimox might be adjusted appropriately during clinical medication in hypoxia. [ABSTRACT FROM AUTHOR]
Copyright of Molecules is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:14203049
DOI:10.3390/molecules27196413